allergan inc (AGN:New York)
Transactions by ALLERGAN INC (AGN) in the last 6 months
Actavis plc (NYSE:ACT) signed a definitive agreement to acquire Allergan Inc. (NYSE:AGN) from HBM Healthcare Investments AG (SWX:HBMN), fund of HBM Partners Ltd., PS Fund 1, LLC, fund of Pershing Square Capital Management, L.P., Paulson & Co. Inc., BlackRock, Inc. (NYSE:BLK) and Pentwater Capital Management LP for $67.4 billion in cash and stock on November 16, 2014. Actavis will acquire Allergan stock for $129.22 in cash and pay stock with the exchange ratio of 0.3683. ...
Allergan Inc. (NYSE:AGN) acquired LiRIS Program in Phase 2 from TARIS BioMedical, Inc. for approximately $590 million in cash on August 13, 2014. Under the terms of the deal, Allergan will pay up to an aggregate of $295 million in development milestone payments and up to an aggregate of $225 million in commercial milestone payments. Jonn Beeson of Jones Day acted as legal advisor for Allergan Inc.
Paulson & Co. Inc. acquired 1.88% stake in Allergan Inc. (NYSE:AGN) on June 26, 2014.
|Actavis plc||$268.18 USD||-2.13|
|Astellas Pharma Inc||¥1,709 JPY||-13.50|
|Medtronic Inc||$72.96 USD||+0.165|
|Regeneron Pharmaceuticals Inc||$414.27 USD||+1.27|
|Shire PLC||4,514 GBp||+46.00|
|View Industry Companies|